RANI: the balance sheet

MyFinsight

For the quarter ending 2026-03-31, RANI has $51,879K in assets. $16,336K in debts. $9,644K in cash and cash equivalents.

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Contract asset	-	0	0	0
Cash and cash equivalents	9,644	18,618	4,144	10,216
Accounts receivable	2,042	2,042	-	-
Marketable securities	33,759	31,091	0	0
Prepaid expenses and other current assets	1,646	1,570	811	857
Total current assets	47,091	53,321	4,955	11,073
Property and equipment, net	601	736	922	1,144
Operating lease right-of-use asset	3,941	4,318	4,017	4,388
Other assets	246	246	245	293
Total assets	51,879	58,621	10,139	16,898

Accounts payable	858	309	2,467	1,798
Current portion of long-term debt	-	0	13,537	15,000
Accrued expenses and other current liabilities	4,706	3,943	2,091	2,636
Long-term debt, less current portion	-	0	0	2,229
Current portion of deferred revenue	6,831	6,831	-	-
Current portion of operating lease liability	1,460	1,586	1,049	1,189
Total current liabilities	13,855	12,669	19,144	20,623
Long-term deferred revenue	0	1,708	-	-
Operating lease liability, less current portion	2,481	2,732	2,968	3,199
Total liabilities	16,336	17,109	22,112	26,051
Common stock, value-Common Class A	9	9	4	3
Common stock, value-Common Class B	2	2	2	2
Common stock, value-Common Class C	0	0	0	0
Additional paid-in capital	168,015	165,578	114,406	111,280
Accumulated other comprehensive (loss)/gain	-8	1	3	3
Accumulated deficit	-139,613	-132,580	-122,275	-116,863
Total stockholders' equity attributable to rani therapeutics holdings, inc	28,405	33,010	-7,860	-5,575
Non-controlling interest	7,138	8,502	-4,113	-3,578
Total stockholders' equity	35,543	41,512	-11,973	-9,153
Total liabilities and stockholders' equity	51,879	58,621	10,139	16,898

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.